Lupin launches generic Loteprednol Etabonate Ophthalmic Suspension in the US market, a bioequivalent to Lotemax, to treat eye ...

Lupin has launched a generic eye medication in the US, aimed at treating inflammation and pain. This new product is a generic ...

Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5%, a generic equivalent to Lotemax, for eye inflammation treatment.

Mumbai: Global pharma major Lupin Limited has launched Loteprednol Etabonate Ophthalmic Suspension, 0.5%, in the United ...

Lupin announced that it has launched Loteprednol Etabonate Ophthalmic Suspension in the United States.

Lupin's share price rose today after the company announced the launch of Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent, in the US market.

On Thursday, 2007 stocks advanced, 2040 declined and 152 remained unchanged on Bombay Stock Exchange with advance decline ...

Aldeyra Therapeutics (ALDX) stock in focus as the FDA accepts its resubmitted marketing application for lead drug reproxalap ...

Karen Fernandez, MD, discusses the different types of treatment currently being tested for use in dry eye disease, which affects millions in the US.

Microplastics larger than 20 µm appear to be routinely present in commercially available eye drops, according to research published in Cornea. The investigation employed the use of micro-Fourier ...

Longer axial lengths, preoperative glaucoma drop use appear to raise the risk for hypotony following vitrectomy for epiretinal membrane.